Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systematic screening for pharmacokinetic interactions during drug development

U Fuhr1, M Weiss, H K Kroemer

  • 1Department of Clinical Pharmacology, Hospital of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.

International Journal of Clinical Pharmacology and Therapeutics
|April 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cardiology: innovative medicine from molecular diagnosis to modern interventional technology].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Personalized medicine in cardiology?].

Herz·2014
Same author

[Research projects for implementation of individualized medicine].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Strategies for personalized medicine-based research and implementation in the clinical workflow.

Clinical pharmacology and therapeutics·2012
Same author

Population imaging as valuable tool for personalized medicine.

Clinical pharmacology and therapeutics·2012
Same author

Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Clinical pharmacology and therapeutics·2012

Predicting drug interactions is crucial for patient safety. This study proposes a mechanism-based approach using in vitro methods and pharmacoepidemiological screening to identify potential pharmacokinetic drug interactions early in development.

Area of Science:

  • Pharmacology
  • Drug Development
  • Toxicology

Background:

  • Pharmacokinetic drug interactions pose significant safety risks.
  • Current methods for evaluating drug interaction potential are often insufficient.
  • A systematic approach is needed to predict and manage drug interactions.

Purpose of the Study:

  • To develop a systematic investigational procedure for identifying drug interactions.
  • To characterize new chemical entities based on their effects on pharmacokinetic processes.
  • To integrate in vitro methods and pharmacoepidemiological screening for comprehensive interaction assessment.

Main Methods:

  • Summarizing interaction mechanisms across absorption, distribution, metabolism, and excretion.
  • Proposing detailed experimental designs to identify a new drug's role in interaction mechanisms.

Related Experiment Videos

  • Integrating in vitro test systems and pharmacoepidemiological screening in early drug development phases.

    • Main Results:

    • The proposed mechanism-based approach allows for rational selection of cost-effective experiments.
    • In vitro systems can predict the occurrence of many drug interactions.
    • Early pharmacoepidemiological screening can identify interactions missed by in vitro methods.

    Conclusions:

    • Implementation of the proposed procedure can avoid most serious unexpected adverse effects from pharmacokinetic drug interactions.
    • A mechanism-based strategy, combined with early screening, enhances drug safety.
    • This systematic approach optimizes the evaluation of drug interaction potential.